Investing.com - U.S. President Donald Trump's reciprocal tariff policy is likely to face an elongated implementation timeline ...

Investing.com - U.S. President Donald Trump's reciprocal tariff policy is likely to face an elongated implementation timeline, but could still be "big," according to analysts at Wolfe Research.

CVS Health (NYSE:CVS – Free Report) had its target price increased by Wolfe Research from 67.00 to 70.00 in a report ...

Wolfe Research Auto, Auto Tech and Semiconductor Conference Call February 12, 2025 12:00 PM ETCompany ParticipantsJohn Wall ...

Wolfe Research Auto, Auto Tech and Semiconductor Conference February 12, 2025 8:50 AM ETCompany ParticipantsMark ...

The internet erupted in controversy over Felisa Wolfe-Simon and colleagues’ claim of a microbe thriving on arsenic. Nearly 15 ...

Ford CEO Jim Farley did not mince words with Wall Street on Tuesday, describing the impact from a lasting 25% tariff as being "devastating." ...

Wolfe Research analyst Myles Walton downgraded Triumph Group (TGI) to Peer Perform from Outperform without a price target after the company ...

CNBC’s Seema Mody and Chris Senyek, Wolfe Research chief investment strategist, join 'Power Lunch' to discuss the Honeywell ...

We recently published a list of 12 AI News and Ratings Investors are Keeping Their Eye On. In this article, we are going to ...